-
Amid early RSV surge, treatment options remain limited
Besides one preventive drug that can only be prescribed in some cases, there are no FDA-approved treatments for respiratory syncytial virus — which leaves healthcare workers with limited treatment options. -
Walgreens VP of pharmacy of the future: Pharmacists can do more
Walgreens' vice president of pharmacy of the future, Rina Shah, PharmD, told Politico federal laws are needed to further meld pharmacists into other healthcare roles. -
Merck CEO to serve as board chairman
The board of directors at pharmaceutical giant Merck elected Robert Davis as chairman, effective Dec. 1. -
UK Healthcare opens 8th retail pharmacy
Lexington-based University of Kentucky Healthcare opened its eighth pharmacy on Oct. 24 in Southeast Lexington. -
Pharmacy's most pressing issue: a technician shortage
At a recent event for community and locally owned pharmacies, William Schimmel, executive director and CEO of the Pharmacy Technician Certification Board, said people were approaching him and asking for "magic" while seeking more technicians. -
University Hospital, Aspirus Health, and 8 other systems seeking pharmacy leaders
The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week. -
Walgreens shakes up pharmacy staff evaluations
Amid a growing cry from pharmacy organizations to boost pharmacists' roles, Walgreens said Oct. 26 that its 24,000 pharmacy workers will soon be evaluated for patient care and outcomes as the company eliminates "all task-based metrics." -
FDA delays meeting to discuss 1st OTC birth control pill
The FDA has postponed its advisory meeting to debate whether HRA Pharma's birth control drug Opill should be authorized for over-the-counter use. -
'We should be reimbursed' for monkeypox vaccinations, California pharmacy owner says
A California pharmacy offering free monkeypox vaccines wants federal funds to help reimburse the business because payers are not reimbursing the pharmacy's efforts, the owner told ABC affiliate KXTV. -
Drug researchers hone in on perimenopause treatments for anxiety, depression
Perimenopause, or the time before menopause begins, usually comes with mood changes, depression and anxiety symtoms. Antidepressants are often prescribed, but researchers are looking for better treatments, The Wall Street Journal reported Oct. 24. -
Pharmacists need to expand their role, CVS report says
CVS released its "Rx Report: A New Day in Retail Pharmacy," which highlighted consumer preference and demand for expanded roles for pharmacists. -
Walgreens partners with DoorDash, Uber to deliver free Paxlovid packets
Online delivery companies DoorDash and Uber will help Walgreens distribute Paxlovid, Pfizer's COVID-19 antiviral drug, to those who have a prescription but cannot access it. -
Omicron boosters aren't better than original vaccine for BA.5, early study suggests
The newly authorized bivalent, omicron-focused boosters elicited a response similar to the fourth dose of the original COVID-19 vaccine formula, according to a preprint study posted Oct. 24. -
COVID-19 vaccine side effects correlated with better antibody response: study
Systemic side effects after receiving a COVID-19 vaccine jab, such as nausea, fever and fatigue, are correlated with higher antibodies, according to a study published Oct. 21 in a JAMA Network Open research letter. -
White House steers addiction-fighting drugs to pregnant people
The Biden administration is planning to broaden the access of substance use disorder drugs to more pregnant people, according to a report released Oct. 21. -
US low on amoxicillin
The antibiotic amoxicillin is in short supply among at least three drugmakers, according to the American Society of Health-System Pharmacists and Bloomberg. -
Colorado hospital uses robotic medication retriever
Grand Junction, Colo.-based St. Mary's Medical Center is making use of the BoxPicker robotics system to package, dispense and retrieve medications. -
Merck referred to HHS inspector general for denying 340B discounts
The Health Resources & Services Administration warned Merck in an Oct. 20 letter that the company may face monetary penalties for refusing to give 340B discounts to covered entities. -
Gov. DeSantis: Florida will not mandate COVID-19 vaccines for children
Following confusion about a CDC panel's vote to recommend COVID-19 vaccines for children's immunization schedules, Florida Gov. Ron DeSantis said the state will not mandate the shots for its pediatric population. -
How COVID-19 therapeutics stack up against BQ.1
When the FDA advised vaccine-makers in late June to engineer their boosters to target subvariants BA.4 and BA.5, at the time the "sister variants" accounted for a slight majority of infections. Four months later, new mutations BQ.1 and BQ.1.1 have surpassed the subvariants the omicron boosters targeted.
Page 50 of 50